Sensex Closes Lower at 74,459; IT and Pharma Shares Lend Support
The Indian stock market ended lower on Friday, as broad-based weakness in midcap and smallcap shares outweighed gains in large-cap counters.
The Sensex closed down 308.49 points, or 0.42 per cent, at 74,459.53. The Nifty ended 116.35 points, or 0.51 per cent, lower at 23,053.10.
The midcap and smallcap segments bore the brunt of the selloff. The Nifty Midcap 100 index fell 540.40 points, or 0.93 per cent, to 57,301.25, while the Nifty Smallcap 100 index tumbled 347.75 points, or 1.85 per cent, to 18,463.60.
Support came mainly from information technology shares. The Nifty IT index climbed 2.32 per cent and the Nifty Healthcare index gained 1.58 per cent, leading the sectoral gainers. The Nifty Pharma index rose 1.55 per cent, the Nifty Services index advanced 1.17 per cent, the Nifty Consumption index inched up 0.29 per cent and the Nifty Infra index ended 0.07 per cent higher.
Sectoral losers included the Nifty India Defence index, which dropped 2.01 per cent, and the Nifty Consumer Durables index, which fell 1.78 per cent. The Nifty Media index lost 1.46 per cent, the Nifty Energy index declined 0.97 per cent, the Nifty PSU Bank index shed 0.93 per cent and the Nifty Auto index slipped 0.87 per cent.
In the Sensex pack, Trent, IndiGo, Infosys, NTPC, Power Grid, Eternal, Tech Mahindra, HUL Tech, HDFC Bank, Kotak Mahindra Bank, Sun Pharma, ITC, Asian Paints, TCS, ICICI Bank, L&T, HUL and Titan closed higher. Losers included SBI, M&M, UltraTech Cement, Tata Steel, Axis Bank, BEL, Reliance Industries, Bajaj Finserv, Bharti Airtel and Maruti Suzuki.
According to market observers, persistent inflation worries kept equities under pressure. The ECB and the Bank of Japan maintained interest rates, mirroring the Federal Reserve's stance. Renewed concerns about AI valuations also reached Asian markets. Meanwhile, fresh news on US-Iran tensions drove crude oil prices higher, further denting market sentiment and triggering heavy selling in midcap and smallcap stocks.
Large caps were relatively resilient, supported by IT stocks, as some investors shifted funds out of global AI shares and made selective purchases. Pharma and healthcare sectors remained strong due to good earnings and defensive demand.